Log in to save to my catalogue

BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma

BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8d09210335ff4eafb1dab8feacb96d23

BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma

Publication information

Publisher

England: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

Plasmablastic lymphoma (PBL) is a rare subtype of aggressive large B-cell lymphoma, with a dismal prognosis despite aggressive therapies. New approaches are needed for those with refractory disease. PBL expresses antigens similar to multiple myeloma (MM), including B-cell maturation antigen (BCMA). Chimeric antigen receptor T-cell (CAR-T) therapy d...

Alternative Titles

Full title

BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8d09210335ff4eafb1dab8feacb96d23

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8d09210335ff4eafb1dab8feacb96d23

Other Identifiers

ISSN

2051-1426

E-ISSN

2051-1426

DOI

10.1136/jitc-2023-006684

How to access this item